CompletedNot Applicable

HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies

United Kingdom149 participantsStarted 2017-09-07

Plain-language summary

This observational clinical cohort study aims to evaluate the clinical utility of LiverMultiScan in quantifying liver health prior to liver resection or TACE. The results will enable further developments in scanning protocols and software, and clearly define the relevance of applying this technology as part of the pre-operative assessment of the patient being considered for liver resection or TACE.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients being considered for liver resection Exclusion Criteria: * i. Patients under the age of 18 years will be excluded from the present study. ii. Prisoners will be excluded from the present study. iii. Persons unable to have an MRI scan (including but not limited to claustrophobia, implanted metallic devices, metal foreign body) iv. Adults with incapacity v. Non-provision of consent

What they're measuring

Correlation between the pre-operative liver health assessment score and the post-operative liver function composite integer-based risk score.

Timeframe: 24 months

Trial details

NCT IDNCT03213314

SponsorUniversity of Edinburgh

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-03-31

View on ClinicalTrials.gov More Liver Cancer trials